EFFECTIVENESS AND TOLERABILITY OF LOW-DOSE CYCLOPHOSPHAMIDE AND LOW-DOSE INTRAVENOUS INTERLEUKIN-2 DISSEMINATED MELANOMA

被引：216

作者：

MITCHELL, MS

KEMPF, RA

HAREL, W

SHAU, H

BOSWELL, WD

LIND, S

BRADLEY, EC

机构：

[1] UNIV SO CALIF,SCH MED,DEPT MED,LOS ANGELES,CA 90033

[2] UNIV SO CALIF,SCH MED,DEPT MICROBIOL,LOS ANGELES,CA 90033

[3] UNIV SO CALIF,SCH MED,DEPT RADIOL,LOS ANGELES,CA 90033

[4] CETUS CORP,EMERYVILLE,CA 94608

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1988年 / 6卷 / 03期

关键词：

D O I：

10.1200/JCO.1988.6.3.409

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：409 / 424

页数：16

共 22 条

[1]

BERD D, 1984, CANCER RES, V44, P1275

[2]

BERD D, 1984, CANCER RES, V44, P5439

[3] AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].

CHEEVER, MA ;

GREENBERG, PD ;

FEFER, A ;

GILLIS, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980

[4]

CUMMINGS FJ, 1986, MED ONCOLOGY, P650

[5]

GILLIS S, 1978, J IMMUNOL, V120, P2027

[6] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[7]

KOLITZ J E, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P235

[8] HIGH-DOSE RECOMBINANT INTERLEUKIN-2 IN THE TREATMENT OF PATIENTS WITH DISSEMINATED CANCER - RESPONSES, TREATMENT-RELATED MORBIDITY, AND HISTOLOGIC-FINDINGS [J].

LOTZE, MT ;

CHANG, AE ;

SEIPP, CA ;

SIMPSON, C ;

VETTO, JT ;

ROSENBERG, SA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (22) :3117-3124

[9]

LOTZE MT, 1985, J IMMUNOL, V135, P1865

[10]

Menck H R, 1985, Natl Cancer Inst Monogr, V69, P105

← 1 2 3 →